Two minute slideshow of people living in an Alzheimer’s facility in Orange County. This project was done for the 2005 OCC Social Issues Documentary Photography Scholarship by Mary Amor.
Video Rating: 4 / 5
Share and Enjoy
Filed under Alzheimer's Info by

Cynthia Lemere of Harvard Medical School shares her findings on the link between inflammation and Alzheimer’s disease. Series: “Inflammation as Cause and Consequence of Disease” [1/2008] [Health and Medicine] [Show ID: 13576]
Share and Enjoy
Filed under Alzheimer's Info by
Performance Network Theatre Will Host a Benefit for the Alzheimer’s Association, Michigan Great Lakes Chapter, Sunday, February 26, 2006
ANN ARBOR, MI (PRWEB) February 22, 2006
Performance Network Theatre is pleased to announce that it will host a Benefit for the Alzheimer’s Association, Michigan Great Lakes Chapter, on Sunday, February 26, 2006. The day’s events will include a conversation with representatives of the Alzheimer’s Association and the Michigan Alzheimer’s Disease Research Center (MADRC), a catered reception, and an evening performance of MOONGLOW by Kim Carney, the critically- acclaimed new play about one family’s struggle with the disease.
One of the artist’s crucial functions is to “create a public forum for discussion on important issues we face as a society,” according to Executive Artistic Director Carla Milarch. “We are so grateful to Kim for giving us all this opportunity to examine an issue that effects so many of us deeply – Alzheimer’s disease and the impact it has on individuals and their families.” As a reflection of our commitment to this principle, Performance Network has assembled a panel of experts, including a neurologist, a caregiver and a social worker, to address the various questions and concerns that arise in any discussion of Alzheimer’s and other dementia disorders.
The panel discussion will take place on Sunday, February 26, 2006 from 4:30pm until 5:30pm, followed by a catered reception in the main lobby of the theatre. The day’s events will culminate in a benefit performance of MOONGLOW at 7:00pm. Admission to the panel and reception is free, tickets to the performance are $ 24.50, with $ 14.50 benefiting the Alzheimer’s Association. Tickets can be purchased at the box office, by telephone at 734-663-0681 or online at http://www.performancenetwork.org.
About the Play:
In this comic-drama, Kim Carney blends her trademark humor with exquisite pathos in the story of a woman moving her mother into an assisted living facility. A tough-as-nails spitfire determined not to go quietly, she causes a ruckus, finds a jitterbugging partner and teaches her daughter a valuable lesson before the play is through. Full of music, dancing and love – and based on the playwright’s own experiences – “Moonglow” will make you want to hug the ones you love just a little bit tighter.
About the Panelists:
Cassie Messmer, LBSW, is the Education and Training Coordinator for the Alzheimer’s Association, Michigan Great Lakes Chapter. She has worked with individuals with dementia and family members for ten years through various organizations, including the Michigan Alzheimer’s Disease Research Center and the Department of Neuropsychology at U of M Hospital. Cassie obtained her Masters in Social Work, with a gerontology focus, from the University of Michigan.
Charlie Duncan is an active volunteer for the Alzheimer’s Association, Michigan Great Lakes Chapter. He was the primary caregiver for his wife, Mary Jane, who was diagnosed with Alzheimer’s disease in 1996. He shares his experiences and memories of his wife through his short stories and poetry.
Dr. Scott Turner is Associate Professor of Neurology at the University of Michigan and Co-Director of the Michigan Alzheimer’s Disease Research Center at the University of Michigan. He is also Chief of the Neurology Service at the VA Ann Arbor Healthcare System. Dr. Turner received his Ph.D. and M.D. from Emory University in Atlanta and did his internship, residency, and fellowship training at the Hospital of the University of Pennsylvania in Philadelphia.
###
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Share and Enjoy
Filed under Alzheimer's Info by
How To Prepare For A Trip To The Emergency Room With Someone Who Has Alzheimer’s
How to Prepare for a Trip to the Emergency Room With Someone Who Has Alzheimer’s
Dementia can complicate already-stressful ER treatment
Preparing ahead of time
Prepare contacts. Make a written list of contacts, including the primary caregiver and other family members or friends who help with care, who should be notified in an emergency. Keep a copy with you in case you get a call about the patient’s condition and can’t come to his side yourself; share copies with other caregivers and facilities he frequents, such as an adult day care center or church program. Note which people have legal permission to be present when physicians and other staff discuss his medical issues.
Prepare records. Anyone who accompanies the patient in the emergency room should bring along a copy of his medical records and relevant legal documents. These include:
A clear summary of his medical condition (including the Alzheimer’s disease and any other health problems)
A list of all the medications, vitamins, and supplements he takes, including dosages
A list of any allergies
Contact information for his primary care physician and any specialists he sees
Insurance and Medicare, Medicaid, or HMO enrollment card(s)
Relevant legal documents, such as a health care proxy, advance health care directive or living will, power of attorney, and do-not-recuscitate order.
Prepare for medical access. A companion who has the patient’s verbal permission to stay by his side should have no problem gaining access. But you can’t count on a verbal okay in a crisis or if he’s already in mid- to late-stage Alzheimer’s. If he’s confused or agitated or unable to grant permission, the hospital staff may require that you present a legal document (such as a health care proxy) that allows you to stay with him — another important reason to obtain this authority soon after his diagnosis. It’s best not to count solely the patient’s spouse for this role, as she or he may be too upset in a crisis (or, in the event of a car accident, for example, also indisposed).
Hospital policies vary. Make sure you let staff know the patient has Alzheimer’s disease and that you are a caregiver (or a son or daughter there in that capacity).
First reactions and dealing with an emergency room
Reacting when an emergency happens
Consult if you can. If possible, call the patient’s doctor about a medical problem before going to the emergency room. Depending on the circumstances, a physician may be able to see an urgent case in the office on short notice. Or she may have advice on how to deal with the situation or the ER specifically.
Don’t drive to the ER. Calling an ambulance is considered safest for someone with Alzheimer’s. Confusion or agitation, which may worsen under stress, can make the ride to the hospital challenging and dangerous (especially if you’re alone with the patient). Note: His insurance may cover some ambulance service providers and not others; it’s useful to check what’s covered now, before a crisis happens.
Bring essentials. Take the essential health and legal records with you, as well as change in case you’re in a hospital area where you can’t use a cell phone. (You don’t want to leave him alone while you step outside.) If you have time and it’s appropriate, bring a comfort item (such as a family photo) along with his medications, a change of clothes, and personal hygiene items (including adult diapers, if used), in case the visit drags on or he needs to be hospitalized.
Navigating the emergency room
What happens first: Triage will likely be the patient’s first stop in the ER. A staff member will record vital signs and a summary of his current medical issue and medical history. Make certain this person notes that the person you’re caring for has Alzheimer’s disease — in fact, tell this to every new medical staffer you encounter. Explain what stage he’s in and that you’re his caregiver (or his son or daughter, there to support and help him). The staff will likely do a brief mental exam and then make a decision about the urgency of his situation. This will determine how quickly he will receive medical care. A frail elderly person with dementia is rated more urgent than a younger person with the same condition, or than a peer without dementia with the same condition.
Once you’ve left triage, if the issue is not life-threatening and you aren’t seen immediately, you’ll register him, which creates a hospital record and involves the presentation of insurance and Medicare/Medicaid information. (In some cases this step may be completed at his bedside.) Then try to find a relatively peaceful, quiet spot in the waiting area where you can sit down.
Stay close. It’s important that you or another trusted helper stay at the patient’s side at all times in the hospital. Any hospital setting, but especially an emergency room, can be intimidating and disorienting to him, and his response can interfere with his care. An ER visit can involve a lot of waiting (often several hours), many questions that require remembering medical history and other facts, and interacting with various strangers — three situations that are stressful to someone with Alzheimer’s.
What to say: When he’s called to be examined, reintroduce yourself and, if necessary, briefly explain again why you need to accompany him: “I’m Mr. Smith’s daughter and I have the legal okay to stay with him, because he has stage 2 Alzheimer’s disease.” He may be examined more than once (for example, first by a resident and then by an attending physician). Be patient and don’t assume that each new face knows about his Alzheimer’s.
What to do: One of your most important contributions will be to listen to the physician’s discharge instructions. The patient is liable to forget or misunderstand them. You’ll likely receive a document describing them; you should read and be sure you understand them before you leave the hospital.
Your role in the ER:
· To calm and reassure the person in your care
· To help answer questions from physicians and other staff
· To ask for assistance if there’s a problem
· To get attention if things seem to reach a standstill
· To listen to the diagnosis and discharge instructions
· To ask questions as needed for clarification
Where to find help: Depending on the patient’s condition and the nature of the discharge instructions, you may want to inquire about discharge planning services. This hospital service, usually provided by a social worker, helps you learn how best to help the patient carry out discharge instructions and handle follow-up care. You will also receive information about other resources, such as visiting-nurse or home-health-aide services.
You should feel free to ask for help from the hospital social worker (or geriatric case manager) if, at any point during the emergency-room treatment, the situation becomes overwhelming, or you need assistance advocating for the patient, or if he must be hospitalized and you need help and advice.
About The Author
Caring.com Editorial Team
Caring.com features original content focused exclusively on eldercare matters. Our 20+ editors and writers research and fact-check every article meticulously, and our advisory board reviews the site regularly to assure the accuracy and relevance of the material we publish. We have hundreds of articles and checklists on health, housing, finance, legal and family issues, and other caregiving concerns, and we’re adding new articles and other resources every day.
Alzheimer’s and Emergency room
Article from articlesbase.com
Share and Enjoy
Filed under Caregiver by
Although there is no cure for the degenerative brain disorder known as Alzheimer’s, the good news is that modern medicine can help slow the disease’s progression.Watch More Health Videos at Health Guru: www.healthguru.com
Share and Enjoy
Filed under Alzheimer's Info by

Alzheimer’s disease usually affects people over the age of 65. Learn what it is like to be a caregiver for a family member who has Alzheimer’s in this disease condition video.
Share and Enjoy
Filed under Caregiver by
Man With Alzheimer’s Bilked by Girlfriend?
Woman’s home searched, but no charges filed yet.
Read more on ABC News
Bulletin Board: Teens, adults invited to Topton talk on stress, free dinner
“Help,” a free community program on teen stress, will be held Sunday from 6 to 8:30 p.m. in the Topton Fire Company social hall, 600 State St. A free spaghetti dinner will be served at 6 by the ladies auxiliary of the company.
Read more on Reading Eagle
Business players – January 7
Charlene Riegger
Read more on The Morning Call
Share and Enjoy
Filed under Elder Law by
Alzheimers Disease
Get paid 60% of every sale. Easy money for you with high converting sales page by pro copywriter. Plus, we are constantly improving copy and your conversions with split-testing.
Alzheimers Disease
Share and Enjoy
Filed under Dementia by
Alzheimer’s disease ? Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that occurs gradually and results in memory loss, behavior changes, and a decline in cognitive abilities. These losses are related to the death of brain cells and the breakdown of the connections between them.
The risk of developing AD increases with age. While it may be that 10% of the population aged over-65 has AD, the percentage of people aged 85 and older with AD is greater than 50 percent! (Table 1) On average, patients with AD live for 8 to 10 years after they are diagnosed, though the disease can last for up to 20 years.
Table 1. Percentage of people affected by Alzheimer’s disease
(Source: Progress Reports on Alzheimer’s Disease 2001)
AD advances by stages, from early, mild forgetfulness to a severe loss of mental function. This loss is called dementia. In most people with AD, symptoms first appear after age 60. The earliest symptoms often include loss of recent memory, faulty judgment, and changes in personality. Often, people in the initial stages of AD think less clearly and forget the names of familiar people and common objects.
Later in the disease, they may forget how to do simple tasks, such as washing their hands. Eventually, people with AD lose all reasoning ability and become dependent on other people for their everyday care. Finally, the disease becomes so debilitating that patients are bedridden and likely to develop other illnesses and infections. Most commonly, people with AD die from pneumonia.
It is estimated that up to 4 million people currently suffer with the disease and the prevalence doubles every 5 years beyond age 65. (Table 2) It is also estimated that approximately 360,000 new cases will occur each year, though this number will increase as the baby boomers are entering their 50′s.
Table 2. Estimation of Alzheimer’s Disease Patients in the U.S. (1998-2020)
Source: Volpe Brown Whelen & Co.
A number of research groups have examined differences in AD prevalence among racial and ethnic groups. Women are slightly more likely to develop AD than men and non-Caucasians (African Americans and Hispanic Americans) have a higher risk of developing AD than Caucasians.
Causes and Treatments
In general, clinical assessment is done by a family physician (PCP). If the diagnostic test, usually Mini-Mental State Exam (MMSE), points to Alzheimer’s disease, then the patient is referred to a neurologist who will then conduct the entire panel of diagnostic tests to confirm the disease. The neurologist may then work with a psychiatrist, geriatricians, pharmacist and social worker to develop a treatment protocol for the patients.
For those who are already suffering from the effects of AD, the most immediate need is to control their symptoms, including problem behaviors such as verbal and physical aggression, agititaion, wandering, depression, sleep disturbances, and delusions.
Currently, the FDA approved four medications for treating AD. All these products act by inhibiting acetylcholinesterase, which breaks down acetylcholine, a neurotransmitter that is important in maintaining cognitive functioning and is lost in patients with AD.(Table 3) These products, however, only provide symptomatic relief on cognitive symptoms and do not stop or reverse the progression of AD. When the disease progresses to a certain stage (usually 2 years), its therapeutic effects disappear and the drugs have to be withdrawn from the patients. Nevertheless, its temporary efficacy has been proven to delay nursing home placement and to reduce deterioration of cognitive performance.
Table 3. Selected product comparison of the Alzheimer’s disease category
Cognex®
Cognex® (tacrine) is the first reversible cholineseterase inhibitor drug approved for improving cognitive symptoms (i.e., memory, attention, reason, language, and the ability to perform simple tasks) associated with Alzheimer’s disease.
The use of Cognex® has been limited by its liver toxicity and an inconvenient dosing schedule. It has been reported that 50% of patients taking Cognex® experienced liver toxicity. As a result, patients on Cognex® require periodic liver function tests to monitor their liver enzyme level.
Furthermore, Cognex® has a cumbersome dosing schedule. While other cholinesterase inhibitors are required to be taken once or twice a daily, Cognex® has to be administered four times daily on an empty stomach.
Aricept®
Aricept® (donepezil) was the second cholinesterase inhibitor approved by the FDA for the treatment of mild to moderate dementia of the Alzheimer’s type.
Unlike the first generation cholinesterase inhibitor, Cognex®, Aricept® has a higher potency and lower incidence of peripheral adverse effect. In clinical studies, Aricept® has been demonstrated to improve memory, language and praxis (the performance of an action). Furthermore, Aricept® has not been associated with liver toxicity which was a major concern among physicians prescribing the first generation cholinesterase inhibitor.
Even though Aricept® has a convenient dosing schedule (the only once-daily chlolinesterase inhibitor) and better tolerability than other products such as Exelon®, it does not offer any significant additional clinical benefits compared with other cholinesterase inhibitors. All the existing cholinesterase inhibitor possess similar efficacy and none of them alter the long-term prognosis of Alzheimer’s disease. As a result, patients who have started taking Aricept® 2 to 4 years ago may experience reduced efficacy and may be required to switch to other drugs. In fact, a recent study demonstrated that 56% of AD patients who have previously failed to benefit from Aricept®, responded to Exelon®.
The initial recommended dose is 5 mg daily before bedtime, with an increase to 10 mg after four to six weeks, according to the patient’s response and tolerance.
Share and Enjoy
Filed under Alzheimer's Info by
Dr. Miguel Pappolla
Drexel Hill Time











